TP53 and melanoma: Triggered by ultraviolet radiation (UVR), BRAFV600E-expressing melanocytes develop canceration through targeting mutation of TP53, which is detected especially in advanced-stage melanomas (Viros et al., 2014; Shain et al., 2015).